vidarabine phosphate has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anasetti, C; Mager, DE; McCune, JS; O'Donnell, PV; Salinger, DH; Sandmaier, BM; Vicini, P | 1 |
1 other study(ies) available for vidarabine phosphate and Myeloproliferative Disorders
| Article | Year |
|---|---|
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Child; Cohort Studies; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid; Lymphocyte Count; Lymphopoiesis; Middle Aged; Models, Biological; Myeloproliferative Disorders; Reproducibility of Results; Retrospective Studies; Transplantation Conditioning; Vidarabine Phosphate; Young Adult | 2015 |